Request for Candidates, Broad-Spectrum Preventatives

• Propose a medical product that defends against respiratory viruses.
• Submit project proposals demonstrating credible pathways to meet Intercept's Target Product Concept through Phase 2 development.
• Design preventatives preventing ≥75% of symptomatic respiratory infections with minimal side effects.
• Apply for funding across exploration through Phase 2 development stages.
• Report milestones, publish results within 12 months, and maintain IP ownership with contingent mission license.

• Propose a medical product that defends against respiratory viruses.
• Submit project proposals demonstrating credible pathways to meet Intercept's Target Product Concept through Phase 2 development.
• Design preventatives preventing ≥75% of symptomatic respiratory infections with minimal side effects.
• Apply for funding across exploration through Phase 2 development stages.
• Report milestones, publish results within 12 months, and maintain IP ownership with contingent mission license.

Intercept is a philanthropic initiative that aims to catalyze the development and deployment of the technologies needed to radically reduce the burden of respiratory infections and eventually eliminate them altogether.